Skip to main contentSkip to navigation
Sirius Investors

Anteris Technologies Global Corp. (AVR) Investment Research Dashboard

About Anteris Technologies Global Corp. (AVR) stock analysis

Get live AVR stock price $8.17, comprehensive Anteris Technologies Global Corp. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time AVR stock data and investment insights.

8.17
0.49%Today
Market Cap
300.56M
Volume
730.57K
52W High
11.05
52W Low
2.99

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is t...

Company Information

CEO
Wayne Geoffrey Paterson
Sector
Healthcare
Industry
Medical - Devices
Employees
174

Contact Information

Address
860 Blue Gentian Road, Suite 340
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Lower volatility stock (Beta: 0.73) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Anteris Technologies Global Corp. shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Anteris Technologies Global Corp.
  • Investors should consider how Anteris Technologies Global Corp. fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

300.56M

P/E Ratio (TTM)

-3.66

Beta

0.73

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

83/100 ⭐⭐⭐⭐⭐

Overall
+0.1%
NYSE
+0.0%
NASDAQ
+0.3%
Sector1D1W1MP/EScore
Healthcare+0.1%+2.6%+1.4%23.5
83/100⭐⭐⭐⭐⭐
Financial Services-0.1%+1.0%+1.8%19.2
82/100⭐⭐⭐⭐⭐
Communication Services+0.7%-2.1%+2.2%22.2
71/100⭐⭐⭐⭐⭐
Consumer Defensive+1.3%+1.6%+0.4%29.2
69/100⭐⭐⭐⭐
Energy+0.1%-0.2%-2.1%19.5
57/100⭐⭐⭐⭐
Basic Materials-0.8%+0.4%-1.9%24.9
56/100⭐⭐⭐⭐
Utilities-1.4%+1.8%-2.6%25.4
47/100⭐⭐⭐
Real Estate-1.3%+1.4%-2.3%29.5
44/100⭐⭐⭐
Consumer Cyclical-0.2%-2.1%-4.5%42.9
16/100
Industrials-1.0%-0.7%-9.4%30.5
14/100
Technology-2.0%-1.2%-5.7%41.9
12/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-27.